Track Order   | Customer Support   | Request Book   |
International Order
BloodBrain Barrier Permeability Changes after Subarachnoid Haemorrhage 1st Editon 2012 Softbound at Meripustak

BloodBrain Barrier Permeability Changes after Subarachnoid Haemorrhage 1st Editon 2012 Softbound

Books from same Author: Antonio F. Germano, Francesco Tomasello

Books from same Publisher: Springer

Related Category: Author List / Publisher List

  • Retail Price: ₹ 8930/- [ 5.00% off ]

    Seller Price: ₹ 8483

Sold By: Book Upload      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 5.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 5.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available


Click for International Orders
  • Provide Fastest Delivery
  • 100% Original Guaranteed
    • General Information  
    Author(s)Antonio F. Germano, Francesco Tomasello
    PublisherSpringer
    Edition1st Editon
    ISBN9783709172506
    Pages130
    BindingSoftbound
    LanguageEnglish
    Publish YearSeptember 2012

    Description

    Springer BloodBrain Barrier Permeability Changes after Subarachnoid Haemorrhage 1st Editon 2012 Softbound by Antonio F. Germano, Francesco Tomasello

    The Concept of the BBB: A Historical Perspective.- Anatomy of the BBB.- Pathophysiology of BBB.- Brain Oedema.- Breakdown of the BBB.- BBB Dysfunction after SAH.- Clinical Monitoring.- Neuroradiological Findings of BBB Dysfunction after SAH.- Computerised Tomography and Magnetic Resonance SPECT and PET.- Experimental Data.- Literature Review of BBB Dysfunction after Experimental SAH.- Qualitative Assessments of BBB Dysfunction after SAH.- Quantitative Assessments of BBB Dysfunction.- Time Course of BBB Dysfunction after SAH.- Additional Pathophysiological Changes after SAH.- Strategies for Pharmacological Intervention.- Hydroxyl Radical Scavenger AVS.- Glutamate Antagonist Felbamate.- Calpain Inhibitor II.- Challenges and Future Direction.- Advances in Cerebrovascular Pathophysiology.- Gene Therapy.- References.